What is the best medicine for rheumatism?

Rheumatoid arthritis should be treated with medication in a timely manner, taking some anti-inflammatory and analgesic drugs, as well as some immunosuppressants. The more common ones are non-steroidal anti-inflammatory drugs, which include meloxicam tablets, indomethacin, Voltaren, etc. Immune preparations generally include Pavlin, methotrexate, etc. You must follow the doctor's orders and use the medication under the doctor's guidance.

Methods of treating rheumatism

1. Rheumatic diseases often affect joints, muscles, bones and soft tissues. The most prominent symptoms are pain, swelling, joint dysfunction and fever. Antipyretic, analgesic and anti-inflammatory treatments are the primary goals of treating this group of diseases, so non-steroidal anti-inflammatory drugs are often used.

2. In addition to symptomatic treatment to relieve symptoms, the treatment of rheumatic diseases also requires etiological treatment, and autoimmune disorders require immune regulation.

3. Arthroscopic treatment can also be used for joint diseases, which greatly improves the efficacy, changes the prognosis of the disease, significantly reduces the disability rate, and improves the patient's quality of life.

Several tips for rheumatoid arthritis

First, joint mobility exercises are very important. The first parts of a rheumatic disease patient to be damaged are the joints, and joint fusion and ankylosis are the main cause of disability in patients. If they are unable to exercise due to fear of pain, they will need strong willpower and may even need to take painkillers to continue.

Second, exercise should be done according to one's ability, combining active exercise with passive exercise, with active exercise as the main focus. When exercising, you should proceed step by step and persist for 15-30 minutes each time. When certain joints have difficulty in active movement due to pathology, you can exercise with the help of others.

Third, the purpose of daily life activity training is to improve the ability to move in daily life and improve the quality of life, so that disabled rheumatic patients can live and work independently without relying on others, whether at home or in society.

Prognosis

In the past decade, with the early combined use of slow-acting antirheumatic drugs, the treatment of extra-articular lesions and the emergence of new therapies, the prognosis of rheumatoid arthritis has been significantly improved. Most people with rheumatoid arthritis can have their condition well controlled or even completely resolved.

Studies have found that the prognosis of rheumatoid arthritis can be roughly determined based on its clinical characteristics in the first year of onset, and certain clinical and laboratory indicators are very meaningful for estimating the condition and guiding medication. In addition, the patient's education level is also related to prognosis. Factors indicating the severity and poor prognosis of rheumatoid arthritis include persistent joint swelling, high titer antibodies, HLA-DR4/DR1 positivity, concomitant anemia, rheumatoid nodules, vasculitis, neuropathy or other extra-articular manifestations.